Connacht Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,639
Closed -$682K 153
2021
Q4
$682K Buy
+6,639
New +$638K 0.67% 55

Other funds holding SYNH

Connacht Asset Management's SYNH Position: Q1 2022 in Review

Connacht Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 6,639 shares — an estimated $682K sold.

Connacht Asset Management first reported a position in SYNH in Q4 2021 and held it in 1 quarter. The position peaked at $682K in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Connacht Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Connacht Asset Management sold 6,639 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $682K.
  • Connacht Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Connacht Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $682K in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Connacht Asset Management's 13F filing for Q1 2022, filed 16 May 2022.